Improving clinical diagnosis in SHOX deficiency: the importance of growth velocity

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pediatric Research

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/pr.2017.247PMID 29211059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.

  2013cited by this paper
• Short Stature before Puberty: Which Children Should Be Screened for SHOX Deficiency?

  2013influential reference
• Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy

  2012cited by this paper
• Genotypes and phenotypes of children with SHOX deficiency in France.

  2012cited by this paper
• Short Stature due to SHOX Deficiency: Genotype, Phenotype, and Therapy

  2011influential reference
• Epidemiology of SHOX deficiency.

  2010cited by this paper
• cDNA cloning of blue gourami (Trichogaster trichopterus) prolactin and its expression during the gonadal cycles of males and females

  2010cited by this paper
• Neonatal Anthropometric Charts: The Italian Neonatal Study Compared With Other European Studies

  2010cited by this paper
• Height Gains in Response to Growth Hormone Treatment to Final Height Are Similar in Patients with SHOX Deficiency and Turner Syndrome

  2009cited by this paper
• Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.

  2008cited by this paper
• Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.

  2007cited by this paper
• Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)

  2006cited by this paper
• Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency

  2006influential reference
• SHOX mutations in idiopathic short stature and Leri‐Weill dyschondrosteosis: frequency and phenotypic variability

  2006cited by this paper
• High incidence of SHOX anomalies in individuals with short stature

  2006cited by this paper
• Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens.

  2004cited by this paper
• Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature.

  2003influential reference
• Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.

  2002cited by this paper
• Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

  2002cited by this paper
• Phenotypes Associated with SHOX Deficiency.

  2001cited by this paper
• Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.

  2000cited by this paper
• Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome.

  1999cited by this paper
• Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome

  1997cited by this paper

• Genetic analysis, ultrasound phenotype, and pregnancy outcomes of fetuses with Xp22.33 or Yp11.32 microdeletions

  2023cites this paper
• Novel heterozygous mutation in the SHOX gene leading to familial idiopathic short stature: A case report and literature review

  2023cites this paper
• Pediatric growth hormone treatment in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact

  2022cites this paper
• Clinical Indications for Growth Hormone Therapy.

  2022cites this paper
• Editorial: Novel Insights Into the Genetics of Growth Disorders

  2022cites this paper
• Copy number variations residing outside the SHOX enhancer region are involved in Short Stature and Léri‐Weill dyschondrosteosis

  2021cites this paper
• Clinical and Genetic Characteristics of 23 Korean Patients with Haploinsufficiency of the Short-stature Homeobox-containing Gene

  2020cites this paper
• Variants in the 5′UTR reduce SHOX expression and contribute to SHOX haploinsufficiency

  2020cites this paper
• Genes that escape from X‐chromosome inactivation: Potential contributors to Klinefelter syndrome

  2020cites this paper
• Novel Clinical Criteria Allow Detection of Short Stature Homeobox-Containing Gene Haploinsufficiency Caused by Either Gene or Enhancer Region Defects

  2020cites this paper
• [Examination of sex chromosome abnormalities in childhood].

  2018cites this paper